Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab monotherapy in adolescents with moderate-to-severe atopic dermatitis
jRCT2080224053Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Tralokinumab with Placebo (2 arms). Started Sep 2018; status: completed.
02
Drugs
tralokinumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080224053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224053.